A Survey on Quetiapine Extended-release Tablets in Patients With Depression in Bipolar Disorder
NCT03403790 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 369
Last updated 2024-10-16
Summary
The purpose of this study is to evaluate the safety and effectiveness of quetiapine in actual clinical settings.
Conditions
Interventions
- DRUG
-
Quetiapine
Oral (extended-release tablet)
Sponsors & Collaborators
-
Astellas Pharma Inc
lead INDUSTRY
Principal Investigators
-
Central Contact · Astellas Pharma Inc
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-01-15
- Primary Completion
- 2020-03-19
- Completion
- 2020-03-19
Countries
- Japan
Study Locations
More Related Trials
-
Study to Evaluate Safety and Tolerability of FK949E in Patients With Major Depressive Disorder
NCT01871974 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy of Seroquel SR in Combination With an Antidepressant in Treatment of Major Depressive Disorder
NCT00351169 ·Status: COMPLETED ·Phase: PHASE3
-
Seroquel in Bipolar Depression Versus Lithium
NCT00206141 ·Status: COMPLETED ·Phase: PHASE3
-
Quetiapine Efficacy in Bipolar Depression Study
NCT00523601 ·Status: COMPLETED
-
Seroquel in Bipolar Depression Versus SSRI
NCT00119652 ·Status: COMPLETED ·Phase: PHASE3
-
Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo and Active Control in Major Depressive Disorder
NCT00321490 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness of Quetiapine XR on the Control of Symptoms of Manic Phase of Bipolar Disorder.
NCT00521365 ·Status: COMPLETED ·Phase: PHASE4
-
Controlled Study of the Use of Quetiapine Fumarate in the Treatment of Patients With Bipolar Depression
NCT00083954 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy & Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I Disorder
NCT00107731 ·Status: COMPLETED ·Phase: PHASE3
-
Quetiapine Fumarate (Seroquel) as Mono-Therapy or Adjunct to Lithium in the Treatment of Patients With Acute Mania in Bipolar Disorder
NCT00672490 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Seroquel and Lithium as Monotherapy in Acute Mania Treatment in Bipolar Disorder Patients
NCT00448578 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Trial of the Use of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Patients With Bipolar Depression
NCT00060489 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I Disorder
NCT00081380 ·Status: COMPLETED ·Phase: PHASE3
-
Quetiapine Fumarate as Monotherapy in the Maintenance Treatment of Patients With Major Depressive Disorder
NCT00278941 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Quetiapine Versus Quetiapine Plus Lithium in Bipolar Depression
NCT00883493 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Quetiapine for the Treatment of Mood Disorders in Adolescents
NCT00221468 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Quetiapine on Ultrastructural Hippocampal and Neurochemical Changes in Patients With Bipolar Disorder: Searching for Antidepressant and Mood Stabilising Neurophysiology
NCT01552837 ·Status: COMPLETED ·Phase: NA
-
A Study to Test the Effect of Different Doses of BI 1358894 and Quetiapine in People With Depression
NCT04521478 ·Status: COMPLETED ·Phase: PHASE2
-
Phase III/Seroquel SR Bipolar Depression Monotherapy - US
NCT00422214 ·Status: COMPLETED ·Phase: PHASE3
-
Quetiapine Fumarate (SEROQUEL) Compared to Placebo in the Treatment of Children & Adolescents With Bipolar I Mania
NCT00090311 ·Status: COMPLETED ·Phase: PHASE3
-
Quetiapine (Seroquel) Maintenance Treatment in Early Onset Bipolar Spectrum Disorders
NCT00252226 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of Flexible Dose of Quetiapine Fumarate (Seroquel) Switching From Other Drugs in the Treatment of Acute Manic Patients With Bipolar Disorder
NCT00837343 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy of Seroquel SR in Combination With an Antidepressant in Treatment of Major Depressive Disorder
NCT00351910 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Quetiapine on Negative Symptoms and Cognition
NCT00305422 ·Status: COMPLETED ·Phase: PHASE3
-
EMR Data to Assess Monitoring of Patients Treated With Quetiapine
NCT01793324 ·Status: COMPLETED